A detailed history of Cutler Group LP transactions in Immutep LTD stock. As of the latest transaction made, Cutler Group LP holds 1,200 shares of IMMP stock, worth $2,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,200
Previous 3,800 68.42%
Holding current value
$2,340
Previous $9,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$1.76 - $2.49 $5,632 - $7,968
3,200 Added 533.33%
3,800 $9,000
Q2 2023

Jul 18, 2023

BUY
$1.54 - $2.62 $924 - $1,572
600 New
600 $1,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $169M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.